biologics mAb case study on reduced time to PPQ tech transfer

Case Study: mAb Tech Transfer Reduced Time to PPQ by 25%

AbbVie Contract Manufacturing is a proven biologics manufacturing leader ranking among the top monoclonal antibody (mAb) production CMOs. In this case study, learn about how a successful Tech Transfer at AbbVie CMO reduced time to Process Performance Qualification (PPQ) by more than 25% to meet commercial needs.

There are many reasons for a pharmaceutical company to perform a tech transfer to a contract manufacturing organization like AbbVie CMO - ranging from simplified logistics to expanding manufacturing capabilities.

This case study describes how AbbVie CMO performed an accelerated tech transfer for a humanized monoclonal antibody (mAb) that was approaching commercialization. Our accelerated process reduced the time to PPQ by 25-50 percent, condensing the tech transfer-to-PPQ timeline from a typical 12-18 months to just nine months.

Download our Tech Transfer Case Study to learn about our strategies for achieving an accelerated tech transfer, including details on onboarding novel raw materials, meeting unique IP requirements, and adapting to process optimizations.

Download mAb Tech Transfer Case Study

There was a problem submitting the form. Please try again later.
required
required
required
required
required

The categories of personal information collected in this form include name, company, and contact information. The personal information collected will be used for exploratory discussions on contract manufacturing, marketing and to perform research and analytics. For more information about the categories of personal information collected by AbbVie and the purposes for which AbbVie uses personal information, visit https://privacy.abbvie.